Nachrichten zur Sanofi S.A. Aktie

Are You Looking for a High-Growth Dividend Stock?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Sanofi Gesundheitstrend: Pharma - eine der drei wichtigsten Branchen

Sanofi-Aventis Deutschland GmbH: Frankfurt/Main (ots) - Wenn es um die Branchen geht, die Menschen in Deutschland für ihr persönliches Leben…

Sanofi (SNY) Gains But Lags Market: What You Should Know

Sanofi (SNY) closed at $51.01 in the latest trading session, marking a +1.09% move from the prior day....…

Form 6-K Sanofi For: Jun 02

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

The Zacks Analyst Blog Highlights Fomento Economico Mexicano, NextEra Energy, Sanofi, NVIDIA and Enbridge

Fomento Economico Mexicano, NextEra Energy, Sanofi, NVIDIA and Enbridge are included in this Analyst Blog....…

Press Release: Sanofi launches 2023 global Employee Stock Purchase Plan

Sanofi launches 2023 global Employee Stock Purchase Plan...…

Top Stock Reports for FEMSA, NextEra Energy & Sanofi

Todays Research Daily features new research reports on 16 major stocks, including Fomento Economico Mexicano, S.A.B. de C.V. (FMX), NextEra…

Sanofi (SNY) NextGen Multiple Sclerosis Drug Meets Phase II Goal

Sanofis (SNY) phase II study on its novel investigational anti-CD40L antibody, frexalimab, meets the primary endpoint....…

Was This $3 Billion Deal a Wise Move for Sanofi?

The French drugmaker appears to have meaningfully improved its portfolio with the acquisition....…

Sanofi mulls pivotal trials for multiple sclerosis candidate after Phase 2 win

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Sanofi Overweight

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Aktie des Pharmakonzerns Sanofi nach einer Veranstaltung zum Thema Nachhaltigkeit…

Sanofi: Frexalimab Phase 2 Trial Meets Primary Goal In Relapsing Multiple Sclerosis

PARIS (dpa-AFX) - French drug major Sanofi S.A. (SNYNF, SNY) announced Wednesday positive Phase 2 data of novel investigational anti-CD40L…

Sanofi announces positive data for frexalimab product to treat multiple sclerosis

...PARIS (Reuters) - French healthcare company Sanofi announced......…

XFRA : DIVIDEND/INTEREST INFORMATION - 30.05.2023 - FR0000120578

Das Instrument SNW FR0000120578 SANOFI SA INHABER EO 2 EQUITY wird ex Dividende/Zinsen gehandelt am 30.05.2023 The instrument…

Sanofi macht Frederic Oudea zum Verwaltungsratschef

Von Giulia Petroni PARIS (Dow Jones)--Sanofi hat Frederic Oudea nach der Hauptversammlung zum Vorsitzenden des Verwaltungsrats ernannt. Der französische…

Sanofi Appoints Frederic Oudea as Chairman of Board of Directors

Sanofi Appoints Frederic Oudea as Chairman of Board of Directors...…

Form 6-K Sanofi For: May 23

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Sanofi Overweight

LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Sanofi auf "Overweight" mit einem Kursziel von 115…

Sanofi Neutral

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Sanofi anlässlich neuer Studiendaten zum Medikament Dupixent auf…

Sanofi:Dupixent Phase 3 COPD Results Presented At ATS & Published In New England Journal Of Medicine

PARIS (dpa-AFX) - Sanofi and Regeneron Pharmaceuticals Inc. (REGN) presented positive Phase 3 results evaluating the investigational use of Dupixent…

U.S. Supreme Court Rules Against Amgen In Cholesterol Drug Patent Dispute With Sanofi

THOUSAND OAKS (dpa-AFX) - The U.S. Supreme Court ruled against Amgen (AMGN) in a long-running patent battle with Sanofi (SNY)…

Sanofi Wins Supreme Court Patent Dispute With Amgen

The court said Amgen patents relating to its cholesterol drug Repatha shouldnt have been granted by the patent office, handing…

Sanofi gewinnt Patenstreit mit Amgen

Von Jan Wolfe WASHINGTON (Dow Jones)----Der Oberste US-Gerichtshof hat entschieden, dass die Patente von Amgen für den Cholesterinsenker Repatha…

Supreme Court rules against Amgen in Repatha patent dispute with Sanofi/ Regeneron

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Sanofi: Information concerning the total number of voting rights and shares – April 2023

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code…

Sanofi: Glänzende Studienergebnisse bezüglich des Einsatzes von Dupixent bei "Raucherlunge" - Aktienanalyse

Wien (www.aktiencheck.de) - Sanofi-Aktienanalyse von der Raiffeisen Bank International AG: Benedikt-Luka Antic, Analyst der Raiffeisen Bank International AG (RBI), rät in…

Rebates or Patent Abuse? Eli Lilly, Novo Nordisk, and Sanofi CEOs Cross Swords with PBMs in Senate Hearing

CEOs of Eli Lilly And Company (NYSE: LLY), Novo Nordisk A/S (NYSE: NVO), Sanofi SA (NASDAQ: SNY), and PBM e read more...…

Sanofi: Nirsevimab Delivers 83% Reduction In RSV Infant Hospitalizations In Phase 3b Trial

PARIS (dpa-AFX) - Sanofi (SNYNF) said new data from the HARMONIE Phase 3b trial showed an 83.21% reduction in hospitalizations…

Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge

He was the only executive to do so before a Senate Health Committee hearing that also included the CEOs of…

Veeva Partners with Sanofi to Transform its Quality System

Leading pharmaceutical company to streamline quality processes across the enterprise PLEASANTON, Calif., May 10, 2023 /PRNewswire/ -- Veeva Systems (NYSE:…

HighRadius ist Leader im Gartner® Magic Quadrant™ 2023 für integrierte Invoice-to-Cash-Anwendungen

HOUSTON, Texas, USA--(BUSINESS WIRE)--HighRadius, der führende Anbieter der Autonomous Finance Platform für das CFO-Büro, ist im Magic Quadrant 2023 for…

Regeneron Posts Higher 1Q Sales, Boosted by Sanofi Work

Regeneron Posts Higher 1Q Sales, Boosted by Sanofi Work...…

Sanofi: COMBINED GENERAL MEETING OF MAY 25, 2023 - AVAILABILITY OF PREPARATORY DOCUMENTS

COMBINED GENERAL MEETING OF MAY 25, 2023...…

BRIEF-New York AG Says Proud To Announce Agreements With Eli Lilly And Sanofi To Cap Insulin Prices At $35 Per Month - Tweet

...May 2 (Reuters) - * NEW YORK AG SAYS PROUD TO ANNOUNCE AGREEMENTS......…

dpa-AFX ProFeed